Chemical Compound

5-PYRIMIDINECARBOXAMIDE, 2-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-6-(((6-FLUORO-2-QUINOLINYL)METHYL)AMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-N-HYDROXY-

CAS Registry Number 1256448-47-1
5-PYRIMIDINECARBOXAMIDE, 2-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-6-(((6-FLUORO-2-QUINOLINYL)METHYL)AMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-N-HYDROXY- 结构式
Primary record

5-PYRIMIDINECARBOXAMIDE, 2-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-6-(((6-FLUORO-2-QUINOLINYL)METHYL)AMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-N-HYDROXY-

库存
5,908 克
纯度
99.3 %
CAS
1256448-47-1

化合物标识与属性

CAS
1256448-47-1
PubChem CID
49857317
SMILES
C1[C@@H]2[C@@H](C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NO
Canonical SMILES
O=C(NO)c1cnc(N2C[C@@H]3C(NCc4ccc5cc(F)ccc5n4)[C@@H]3C2)nc1

名称与同义词

  • Nanatinostat
  • CHR-3996
  • Nanatinostat [USAN]
  • Hdac inhibitor CHR-3996
  • CTEP
  • Nanatinostat (USAN)
  • YTL7A418KQ
  • UNII-YTL7A418KQ
  • 1256448-47-1
  • NANATINOSTAT [INN]
  • D0T4QX
  • VRX-3996
  • CHEMBL1801250
  • NANATINOSTAT [WHO-DD]
  • GTPL8391
  • orb1706928
  • CHR 3996
  • SCHEMBL22712412
  • SCHEMBL22712415
  • SCHEMBL22712419
  • SCHEMBL29453926
  • CHR3996
  • MGluR5 antagonist (oral), Roche
  • WHO 10911
  • BDBM50347385
  • EX-A10961
  • AKOS040742271
  • DB15419
  • SB16879
  • compound 21r [PMID 21080647]
  • DA-51875
  • HY-13432
  • MS-26622
  • CS-0006885
  • J3.728.787C
  • J3.728.790C
  • D11442
  • A939027
  • Q27075994
  • Metabotropic glutamate receptor 5 antagonist (oral), Roche
  • 2-[(1S,5R)-6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide
  • 2-((1alpha,5alpha,6alpha)-6-(((6-Fluoro-2-quinolinyl)methyl)amino)-3-azabicyclo(3.1.0)hex-3-yl)-N-hydroxy-5-pyrimidinecarboxamide
  • 5-Pyrimidinecarboxamide, 2-((1alpha,5alpha,6alpha)-6-(((6-fluoro-2-quinolinyl)methyl)amino)-3-azabicyclo(3.1.0)hex-3-yl)-N-hydroxy-
  • 1235859-13-8
  • 2-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-6-(((6-FLUORO-2-QUINOLINYL)METHYL)AMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-N-HYDROXY-5-PYRIMIDINECARBOXAMIDE
  • 2-(6-(((6-Fluoroquinolin-2-yl)methyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-n-hydroxypyrimidine-5-carboxamide
  • 2-[(1R,5S)-6-{[(6-fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide
  • 2-[(1R,5S,6R)-6-{[(6-fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide
  • 2-[(1R,5S,6S)-6-{[(6-Fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hex-3-yl]-N-hydroxypyrimidine-5-carboxamide
  • 2-[(1R,5S,6S)-6-{[(6-fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide
  • 5-PYRIMIDINECARBOXAMIDE, 2-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-6-(((6-FLUORO-2-QUINOLINYL)METHYL)AMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-N-HYDROXY-
  • 5-Pyrimidinecarboxamide, 2-[(1a,5a,6a)-6-[[(6-fluoro-2-quinolinyl)methyl]amino]-3-azabicyclo[3.1.0]hex-3-yl]-N-hydroxy-
  • N/A